• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GALVANIZE THERAPEUTICS ALIYA SYSTEM; LOW ENERGY DIRECT CURRENT THERMAL ABLATION SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GALVANIZE THERAPEUTICS ALIYA SYSTEM; LOW ENERGY DIRECT CURRENT THERMAL ABLATION SYSTEM Back to Search Results
Patient Problem Nodule (4551)
Event Date 03/23/2023
Event Type  Injury  
Event Description
This report is in regards to questionable business practices with regard to the galvanize/aliya system.They are marketing this product as effective for treatment of pulmonary nodules.We tried it in 5 patients and it did not work at all.This is exceedingly dangerous as it is pulmonary ablation of lung nodules is a high risk procedure.We are publishing our experience now.However, this may not be enough to get the word out.I am getting word that they are aggressively selling this product to the ir community.I think this company is too focused on profits and not the outcomes of cancer patients.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALIYA SYSTEM
Type of Device
LOW ENERGY DIRECT CURRENT THERMAL ABLATION SYSTEM
Manufacturer (Section D)
GALVANIZE THERAPEUTICS
MDR Report Key19003897
MDR Text Key339064063
Report NumberMW5153364
Device Sequence Number1
Product Code OAB
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Physician
Type of Report Initial
Report Date 03/26/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received03/28/2024
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age50 YR
Patient SexMale
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-